Next Article in Journal
siRNA Genome Screening Approaches to Therapeutic Drug Repositioning
Previous Article in Journal
Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges
Previous Article in Special Issue
Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease
Pharmaceuticals 2013, 6(1), 108-123; doi:10.3390/ph6010108

Notes on Article Versions

Action Date Notes Link
article pdf uploaded. 18 January 2013 09:30 CET Version of Record http://www.mdpi.com/1424-8247/6/1/108/pdf-vor
article pdf uploaded. 21 January 2013 14:40 CET Updated version of record http://www.mdpi.com/1424-8247/6/1/108/pdf
article xml uploaded. 21 January 2013 14:40 CET Original file -
article html file updated 21 January 2013 14:40 CET Original file -
article html file updated 24 January 2013 12:28 CET Update -
article html file updated 7 February 2013 17:53 CET Update -
article html file updated 8 February 2013 09:33 CET Update -
article xml file uploaded 13 September 2013 17:16 CEST Update http://www.mdpi.com/1424-8247/6/1/108/xml
article html file updated 13 September 2013 17:17 CEST Update -
article html file updated 17 June 2015 05:37 CEST Update http://www.mdpi.com/1424-8247/6/1/108/html
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert